These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


158 related items for PubMed ID: 4353212

  • 1. The role of antibody and host cells in the resistance of mice against infection by coxsackie B-3 virus.
    Rager-Zisman B, Allison AC.
    J Gen Virol; 1973 Jun; 19(3):329-38. PubMed ID: 4353212
    [No Abstract] [Full Text] [Related]

  • 2. Effects of immunosuppression on coxsackie B-3 virus infection in mice, and passive protection by circulating antibody.
    Rager-Zisman B, Allison AC.
    J Gen Virol; 1973 Jun; 19(3):339-51. PubMed ID: 4723533
    [No Abstract] [Full Text] [Related]

  • 3. Generation of cytotoxic T lymphocytes during coxsackievirus tb-3 infection. II. Characterization of effector cells and demonstration cytotoxicity against viral-infected myofibers1.
    Wong CY, Woodruff JJ, Woodruff JF.
    J Immunol; 1977 Apr; 118(4):1165-9. PubMed ID: 300400
    [Abstract] [Full Text] [Related]

  • 4. Generation of cytotoxic T lymphocytes during coxsackievirus B-3 infection. I. Model and viral specificity1.
    Wong CY, Woodruff JJ, Woodruff JF.
    J Immunol; 1977 Apr; 118(4):1159-64. PubMed ID: 300399
    [Abstract] [Full Text] [Related]

  • 5. A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice.
    Ku Z, Liu Q, Ye X, Cai Y, Wang X, Shi J, Li D, Jin X, An W, Huang Z.
    Vaccine; 2014 Jul 23; 32(34):4296-303. PubMed ID: 24950363
    [Abstract] [Full Text] [Related]

  • 6. Peroral infection with group B coxsackievirus in the adult mouse: protective functions of the gut.
    Loria RM, Kibrick S, Broitman SA.
    J Infect Dis; 1974 Nov 23; 130(5):539-43. PubMed ID: 4423592
    [No Abstract] [Full Text] [Related]

  • 7. Interaction of mouse peritoneal macrophages with fixed rabies virus in vivo and in vitro.
    Turner GS, Ballard R.
    J Gen Virol; 1976 Feb 23; 30(2):223-31. PubMed ID: 181533
    [Abstract] [Full Text] [Related]

  • 8. [Dynamics of level of peritoneal exudate cellular elements in BALB/c mice infected with Coxsackie virus A13].
    Bocharov EF, Shestenko OP, Meleshina OB.
    Biull Eksp Biol Med; 1995 Jul 23; 120(7):75-7. PubMed ID: 8527789
    [No Abstract] [Full Text] [Related]

  • 9. [Study of Coxsackie A 10 virus infection in newborn and suckling mice of the strains A2G, ICR-K and CBA].
    Voiculescu C, Stanciu L, Rogoz S, Blaj-Băjeu S, Tomescu R, Tăţulescu M.
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1980 Jul 23; 25(1):35-43. PubMed ID: 6154959
    [Abstract] [Full Text] [Related]

  • 10. [Persistent infection caused by the Coxsackie B3 virus in adult mice].
    Goriunova AG, Savinov AP.
    Vopr Virusol; 1987 Jul 23; 32(2):213-6. PubMed ID: 3037797
    [Abstract] [Full Text] [Related]

  • 11. [Extraction of immune ascitic fluids against group A Coxsackie viruses from white rats].
    Mikhaĭlovskaia TA, Linevich ZK, Konovalova OM.
    Vopr Virusol; 1973 Jul 23; 18(5):609-11. PubMed ID: 4789251
    [No Abstract] [Full Text] [Related]

  • 12. Immunization of mice against Coxsackievirus B3 and prevention of foetal growth retardation.
    Lansdown AB, Brown JD.
    Br J Exp Pathol; 1976 Oct 23; 57(5):521-4. PubMed ID: 999788
    [Abstract] [Full Text] [Related]

  • 13. ENTEROVIRUS ANTIBODIES IN MOUSE ASCITIC FLUIDS AFTER IMMUNIZATION.
    FABIYI A, WENNER HA.
    J Immunol; 1965 Feb 23; 94():257-61. PubMed ID: 14265896
    [No Abstract] [Full Text] [Related]

  • 14. [Immunity response of 3 animal species (guinea pigs, hamsters, mice) to various Coxsackie viruses of group A. II. Study of antibodies detected by gel immunodiffusion: comparison with complement fixing antibodies].
    Bringuier JP, Gaudin OG, Brigaud M, Terraillon J, Sohier R.
    Ann Inst Pasteur (Paris); 1971 Oct 23; 121(4):551-61. PubMed ID: 5004043
    [No Abstract] [Full Text] [Related]

  • 15. Generation of cytotoxic T lymphocytes during coxsackievirus B-3 infection. III. Role of sex.
    Wong CY, Woodruff JJ, Woodruff JF.
    J Immunol; 1977 Aug 23; 119(2):591-7. PubMed ID: 301899
    [No Abstract] [Full Text] [Related]

  • 16. [Interactions of some viruses with peritoneal macrophages].
    Suptel' EA, Maksimovich NA.
    Dokl Akad Nauk SSSR; 1971 Feb 01; 196(4):959-61. PubMed ID: 4325126
    [No Abstract] [Full Text] [Related]

  • 17. Involvement of T lymphocytes in the pathogenesis of coxsackie virus B3 heart disease.
    Woodruff JF, Woodruff JJ.
    J Immunol; 1974 Dec 01; 113(6):1726-34. PubMed ID: 4610045
    [No Abstract] [Full Text] [Related]

  • 18. Post-coxsackie virus B3 myocardiopathy in mice.
    Feinstone SM, Hensley GT, Rytel MW.
    Proc Soc Exp Biol Med; 1973 Oct 01; 144(1):345-50. PubMed ID: 4589215
    [No Abstract] [Full Text] [Related]

  • 19. [Preparation of diagnostic reagents for coxsackie A viruses (author's transl)].
    Petrovicová A, Simková A.
    Cesk Epidemiol Mikrobiol Imunol; 1974 May 01; 23(3):168-72. PubMed ID: 4280956
    [No Abstract] [Full Text] [Related]

  • 20. [Diabetogenic properties of Coxsackie A13 and Coxsackie B4 viruses in experimental infection in mice].
    Bocharov EF, Shorin IuP, Solodovnikova IA, Kazarian LS, Seliatitskaia VG.
    Vopr Virusol; 1988 May 01; 33(4):469-74. PubMed ID: 2848368
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.